Cited by 84

Blood β‐hydroxybutyrate vs. urine acetoacetate testing for the prevention and management of ketoacidosis in Type 1 diabetes: a systematic review

Klocker, A. A., Phelan, H., Twigg, S. M., Craig, M. E.·2013·Diabetic Medicine

Abstract

Abstact: Aim: Diabetic ketoacidosis is a life‐threatening complication of Type 1 diabetes. Blood β‐hydroxybutyrate testing is now widely available as an alternative to urine acetoacetate testing for detecting ketosis. The aim of this study was to review the effectiveness of capillary or serum β‐hydroxybutyrate compared with urine acetoacetate testing in prevention and management of diabetic ketoacidosis. Methods: MEDLINE , EMBASE , EBM Reviews, The Cochrane Library and CINAHL (until April 2012, no language restrictions, studies in humans) were searched for experimental and observational studies comparing the effectiveness of blood β‐hydroxybutyrate and urine acetoacetate testing. Outcomes examined were prevention of diabetic ketoacidosis, time to recovery from diabetic ketoacidosis, healthcare costs and patient or caregiver satisfaction. Additional sources included reference lists, conference proceedings and contact with experts in the field. Results: Four studies (two randomized controlled trials and two cohort studies) met eligibility criteria, including 299 participants across 11 centres. Risk of bias was low to moderate. Blood ketone testing compared with urine testing was associated with reduced frequency of hospitalization (one study), reduced time to recovery from diabetic ketoacidosis (three studies), cost benefits (one study) and greater satisfaction (one study, intervention group only). No study assessed prevention of diabetic ketoacidosis. Meta‐analysis could not be performed because of heterogeneity in study design and published data. Conclusions: There is evidence suggesting that blood β‐hydroxybutyrate testing is more effective than urine acetoacetate testing in reducing emergency department assessment, hospitalization and time to recovery from diabetic ketoacidosis, as well as potentially lowering healthcare expenditure. Further research in both young people and adults is needed.

Integrity signals

Registry

Crossref · 10.1111/dme.12136

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cited by

Sorted by citations

Authors
Klocker, A. A., Phelan, H., Twigg, S. M., & Craig, M. E.
Affiliations
  • School of Women's and Children's Health University of New South Wales Sydney NSW Australia
  • John Hunter Children's Hospital Newcastle NSW Australia
  • Faculty of Medicine University of Sydney NSW Australia
Venue
Diabetic Medicine
Publisher
Wiley
Published
2013-06-23
Volume
30
Issue
7
Pages
818-824
ISSN
  • 0742-3071
  • 1464-5491
Cited by
84
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review